View Older Stories View More Recent Stories

Apr 24, 2025 08:00AM PTC Therapeutics to Participate at Upcoming Investor Conferences
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Dec 2, 2024 04:12PM RBC Capital Upgrades PTC Therapeutics (PTCT) to Outperform, 'NVS HD Deal Meaningfully Improves Fundamentals'
May 2, 2024 08:00AM PTC Therapeutics to Participate at Upcoming Investor Conferences
Jun 23, 2022 05:17AM PTC Therapeutics (PTCT) PT Raised to $46 at RBC Capital
Jun 21, 2022 09:40AM RBC Capital on PTC Therapeutics (PTCT): 'Data Should Be Good Enough for Translarna to Stay on EU Mkt'
Apr 29, 2022 04:30PM PTC Therapeutics to Participate at Upcoming Investor Conferences
Apr 27, 2021 08:00AM PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences
Nov 30, 2020 06:10AM UPDATE: RBC Capital Downgrades PTC Therapeutics (PTCT) to Underperform
May 5, 2020 08:00AM PTC Therapeutics to Participate at Upcoming Investor Conferences
Feb 20, 2020 05:07AM RBC Capital Downgrades PTC Therapeutics (PTCT) to Sector Perform
Dec 5, 2019 06:44AM PTC Therapeutics (PTCT) PT Raised to $58 at RBC Capital
Sep 24, 2019 07:59AM UPDATE: PTC Therapeutics (PTCT) Management Conversation Implies Upside From Gene Therapy - RBC Capital
Aug 7, 2019 07:02AM PTC Therapeutics (PTCT) PT Raised to $50 at RBC Capital
May 8, 2019 08:00AM PTC Therapeutics to Participate at Upcoming Investor Conferences
May 3, 2019 06:32AM PTC Therapeutics (PTCT) PT Raised to $42 at RBC Capital
Mar 19, 2019 01:27PM PTC Therapeutics (PTCT) Risdiplam's Competitive Potential Highlighted - RBC
Feb 25, 2019 04:30PM PTC Therapeutics Announces Partial Exercise of Underwriter's Option to Purchase Additional Shares
Feb 22, 2019 07:54AM PTC Therapeutics (PTCT) PT Raised to $40 at RBC Capital Following Deep Dive
Jan 23, 2019 09:30AM Pre-Open Stock Movers 01/23: (ATHX) (SYF) (RIGL) Higher; (BLPH) (TSE) (PTCT) Lower (more...)
Jan 23, 2019 08:56AM PTC Therapeutics (PTCT) Prices 6.72M Common Stock Offering at $30.20/Share
Jan 23, 2019 08:55AM PTC Therapeutics Announces Pricing of Public Offering of Common Stock
Jan 22, 2019 04:09PM PTC Therapeutics (PTCT) to Offer $200M in Common Stock
Jan 22, 2019 04:08PM PTC Therapeutics Announces Proposed Public Offering of Common Stock
Nov 6, 2018 06:46AM PTC Therapeutics (PTCT) PT Lowered to $46 at RBC Capital
Aug 28, 2018 07:33AM RBC Capital Remains Bullish on PTC Therapeutics (PTCT) Following Waylivra CRL
Aug 8, 2018 08:50AM PTC Therapeutics (PTCT) PT Raised to $51 at RBC Capital
Jun 18, 2018 06:47AM RBC Capital Upgrades PTC Therapeutics (PTCT) to Outperform Following 'Compelling' SMA Data
May 31, 2018 03:56PM RBC Positive on Biogen (BIIB) Karp Hire Amid Partnerships/M&A Potential
May 31, 2018 12:50PM Roche's SMA Update is 'Incrementally Positive' for PTC Therapeutics (PTCT) - RBC
May 10, 2018 08:51AM PTC Therapeutics (PTCT) PT Lowered to $30 at RBC Capital
Apr 12, 2018 04:30PM PTC Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
Mar 29, 2018 05:39AM PTC Therapeutics (PTCT) Prices 4M Share Offering at $27.04/Sh
Mar 28, 2018 07:15PM PTC Therapeutics Announces Pricing of Public Offering of Common Stock
Mar 27, 2018 04:05PM PTC Therapeutics (PTCT) Commences 4M Share Offering of Common Stock
Mar 27, 2018 04:04PM PTC Therapeutics Announces Proposed Public Offering of Common Stock
Feb 9, 2018 08:00AM PTC Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
Jan 29, 2018 09:29AM Pre-Open Movers 01/29: (IMMR) (DPS) (KS) Higher; (CYOU) (SOHU) (ADNT) Lower (more...)
Jan 29, 2018 08:28AM RBC Capital Assumes PTC Therapeutics (PTCT) at Sector Perform
Apr 10, 2017 04:01PM PTC Therapeutics (PTCT) Announces Departure of CFO, Shane Kovacs
Apr 10, 2017 04:01PM PTC Therapeutics Announces Departure of Chief Financial Officer, Shane Kovacs
Mar 6, 2017 11:44AM RBC Capital Maintains Sector Perform and $13 PT on PTC Therapeutics (PTCT); NDA for Ataluren Filed Under Protest with FDA
Nov 11, 2016 12:57PM PTC Therapeutics' (PTCT) Price Target Raised to $13 at RBC Capital
Oct 17, 2016 11:21AM RBC Affirms PTC Therapeutics (PTCT) at 'Sector Perform'; Doesn't See Translarna Appeal with Solid Chance
Apr 15, 2016 12:32PM PTC Therapeutics (PTCT) NICE-Related News a Positive, But Could Be 'Short-Lived' - RBC
Mar 1, 2016 08:54AM RBC Cuts PTC Therapeutics (PTCT) Price Target by Nearly 20%
Feb 25, 2016 09:23AM Pre-Open Stock Movers 02/25: (POWR) (GTLS) (TREE) (CRM) Higher; (RATE) (RH) (RLYP) Lower (more...)
Feb 24, 2016 06:55AM RBC Capital Downgrades PTC Therapeutics (PTCT) to Sector Perform
Jan 28, 2016 04:30PM PTC Therapeutics to Participate at Upcoming Investor Conferences
View More Recent Stories View Older Stories